J&J Announces Proposed $5.5 Billion Settlement of 76,000 Ovarian Talc Claims
Johnson & Johnson announced a proposed $5.5 billion resolution of about 76,000 ovarian cancer talc claims on July 27, 2026, five days after the MDL court ordered plaintiffs to show why their claims should not be dismissed. The deal requires 95% participation, covers existing claims only, and excludes mesothelioma. Per-claim values have not been published.